Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M46.8Revenue (TTM) $M24.8Net Margin (%)-71.6Altman Z-Score-1.7
Enterprise Value $M172EPS (TTM) $-3.3Operating Margin %-108.8Piotroski F-Score1
P/E(ttm)--Beneish M-Score11.8Pre-tax Margin (%)-66.0Higher ROA y-yY
Price/Book0.610-y EBITDA Growth Rate %-27.7Quick Ratio3.8Cash flow > EarningsN
Price/Sales2.25-y EBITDA Growth Rate %-18.4Current Ratio4.2Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-5.7Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-57.6Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M14.6ROIC % (ttm)-68.8Gross Margin Increase y-yN

Gurus Latest Trades with OREX

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
OREXSeth Klarman 2016-03-31 Add0.16%$5.22 - $19.2
($12.98)
$ 3.21-75%Add 881.68%2,226,840
OREXSeth Klarman 2015-12-31 Add0.04%$15.7 - $33.2
($23.89)
$ 3.21-87%Add 176.17%226,840
OREXSeth Klarman 2015-09-30 Buy 0.03%$20.4 - $49.3
($34.26)
$ 3.21-91%New holding82,136
OREXGeorge Soros 2012-06-30 Sold Out -0.03%$31.2 - $59
($37.74)
$ 3.21-91%Sold Out0
OREXGeorge Soros 2012-03-31 Buy 0.03%$16.7 - $50.1
($32.98)
$ 3.21-90%New holding50,000
OREXFirst Eagle Investment 2010-09-30 Sold Out -0.01%$39 - $67.7
($49.82)
$ 3.21-94%Sold Out0
OREXFirst Eagle Investment 2010-06-30 Add$40.5 - $70.4
($55.5)
$ 3.21-94%Add 74.07%47,000
OREXFirst Eagle Investment 2010-03-31 Add$58.9 - $72.4
($65.09)
$ 3.21-95%Add 22.73%27,000
OREXFirst Eagle Investment 2009-12-31 Add0.01%$64.4 - $93.9
($76.72)
$ 3.21-96%Add 83.33%22,000
OREXFirst Eagle Investment 2009-09-30 Buy 0.01%$52 - $103.4
($79.1)
$ 3.21-96%New holding12,000
OREXBill Gates 2009-06-30 Sold Out $18.9 - $52.1
($32.26)
$ 3.21-90%Sold Out0
OREXBill Gates 2009-03-31 Buy $23.4 - $62.7
($40.16)
$ 3.21-92%New holding1,390
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

OREX is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


OREX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Moglia Stephen A.VP, Chief Accounting Officer 2016-12-19Sell800$1.9663.78view
Booth Mark DChief Commercial Officer 2015-02-26Sell5,000$56.8-94.35view
Turner Heather DSVP, Gen. Counsel & Secretary 2014-12-02Sell2,264$60-94.65view
Turner Heather DSVP, Gen. Counsel & Secretary 2014-11-25Sell3,139$58.3-94.49view
BOCK LOUIS CDirector 2014-11-18Buy133$55.8-94.25view
BOCK LOUIS CDirector 2014-11-12Buy2,705$55.7-94.24view
Turner Heather DVP, Gen. Counsel & Secretary 2014-09-22Sell30,000$44.7-92.82view
NARACHI MICHAELPresident and CEO 2014-09-15Buy5,000$47.8-93.28view
Hagan Joseph PSr. VP, Corporate Development 2014-09-15Buy500$46.9-93.16view
Hagan Joseph PChief Business Officer 2013-07-31Sell1,200$78-95.88view

Quarterly/Annual Reports about OREX:

News about OREX:

Articles On GuruFocus.com
Seth Klarman’s Largest New Buys and Adds Feb 15 2016 
Value Investing in BioPharma Nov 18 2015 
Seth Klarman Buys Pharmaceutical Company's Shares to Fund Drug Launch Oct 12 2015 
Oxford Industries (OXM) Solid Growth Metrics, Orexigen Therapeutics (OREX) European Anti-Obesity App Mar 27 2015 
Orexigen Therapeutics' Bright Future Mar 03 2015 
Revisiting Arena, Orexigen, And VIVUS: Shareholders Can Recoup Their Losses By Invest In MannKind Aug 19 2014 
Weekly CEO Sells Highlight: Orexigen Therapeutics Inc, Gas Natural Inc, The Middleby Corporation, an Jul 15 2012 
Weekly CEO Sells Highlight: Gas Natural Inc, Encore Bancshares Inc, Staples Inc, and Orexigen Therap Jul 08 2012 
Arena Facing Increased Pressure from Peers Apr 23 2012 
Arena Could Dip If Lorcaserin Fails Again Apr 22 2012 

More From Other Websites
OREXIGEN THERAPEUTICS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and... Jan 12 2017
Orexigen Therapeutics (OREX) Shares March Higher, Can It Continue? Jan 10 2017
Celgene Issues Preliminary 2016 Results, Lifts 2017 View Jan 10 2017
OREXIGEN THERAPEUTICS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and... Jan 09 2017
Orexigen Therapeutics Announces Publication of Contrave® (naltrexone HCl and bupropion HCl... Jan 06 2017
Orexigen Therapeutics Announces Publication of Contrave® (naltrexone HCl and bupropion HCl... Jan 06 2017
Orexigen Therapeutics Highlights Key Business Priorities for 2017 Jan 05 2017
Orexigen Therapeutics Highlights Key Business Priorities for 2017 Jan 05 2017
Wednesday’s Top 5 Biopharma Movers Jan 04 2017
Orexigen Therapeutics Launches "Brains Behind Weight Loss," a Dynamic Patient Focused Campaign to... Jan 03 2017
Orexigen Therapeutics Launches "Brains Behind Weight Loss," a Dynamic Patient Focused Campaign to... Jan 03 2017
OREXIGEN THERAPEUTICS, INC. Files SEC form 8-K, Other Events Dec 30 2016
15 Stocks With The Highest Forecast Sales Growth Dec 23 2016
ETFs with exposure to Orexigen Therapeutics, Inc. : December 21, 2016 Dec 21 2016
OREXIGEN THERAPEUTICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement,... Dec 20 2016
Orexigen Therapeutics Announces Commercialization and Distributorship Agreement with Biologix FZCO... Dec 19 2016
Orexigen Therapeutics Announces Commercialization and Distributorship Agreement with Biologix FZCO... Dec 19 2016
Orexigen Therapeutics to Present at the 35th Annual J.P. Morgan Healthcare Conference 2017 Dec 19 2016
Should You Avoid Orexigen Therapeutics, Inc. (OREX)? Dec 12 2016
ETFs with exposure to Orexigen Therapeutics, Inc. : December 9, 2016 Dec 09 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)